{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"5"}],"units":"Participants"}],"description":"Overall response rate (ORR) is defined as the percentage of participants achieving a partial response or better (≥PR) per IMWG criteria. The number and percentage of participants achieving at least a partial response were reported.\n\nComplete response (CR) requires negative serum and urine immunofixation, disappearance of plasmacytomas, and \\<5% bone marrow plasma cells; stringent complete response (sCR) requires CR plus a normal free light chain ratio and no clonal plasma cells in bone marrow. Very good partial response (VGPR) is defined as M-protein detectable by immunofixation but not electrophoresis, or a ≥90% reduction in serum M-protein with urine M-protein \\<100 mg/24h. Partial response (PR) is defined as a ≥50% reduction in serum M-protein and a ≥90% reduction in 24-hour urine M-protein (or to \\<200 mg/24h), with a ≥50% reduction in plasmacytomas if present at baseline.","groups":[{"description":"Subjects with relapsed or refractory multiple myeloma receiving the study treatment.","id":"OG000","title":"Experimental: Single Arm"}],"paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"Participants received study treatment for up to 12 weeks, at which point tumor response was assessed.","reportingStatus":"POSTED","timeFrame":"Up to 12 weeks","title":"Overall Response Rate (ORR)","type":"PRIMARY","unitOfMeasure":"Participants"}